See what your fund actually adds
Franklin Genomic Advancements ETF HELX
Historical return decomposition and an investable replication portfolio, using data through 2026-10-09.
Fund and replication metrics
| Measure | HELX | Replication |
|---|---|---|
| Annualized growth | -3.1% | 6.3% |
| Annualized volatility | 24.2% | 16.8% |
| Sharpe ratio | -0.01 | 0.45 |
| Maximum drawdown | 53.0% | 25.1% |
| Replication fit (R²) | 0.70 · Tracking error 13.2% | |
Replication portfolio
The published portfolio below is the investable basket used to model HELX’s historical return behavior.
| Ticker | Building block | Weight |
|---|---|---|
| VBK | Small-Cap · Growth | 53.5% |
| XLV | Sector · Healthcare | 46.5% |